Sign in
CompletedNo phase

Effectiveness of AI-Guided Exercise and Pain Neuroscience Education for Fibromyalgia (FIBROIA)

Key facts

Who runs it
Instituto Neurociencia Del Dolor
Where
Chile and Colombia2 sites in 2 countriesChoose a country to see its sites
Trial code
Status
Completed
People taking part
50 people enrolled
Started
10 Feb 2026
Ended
14 Jun 2026
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • AI-Guided Exercise and Pain Neuroscience Education
  • Enhanced Usual Care for Fibromyalgia
Record updated
19 August 2026

Who can take part

Age
18 years to 65 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 8 criteriaShow less

Who can take part

  • Clinical diagnosis of fibromyalgia according to the American College of Rheumatology criteria (2016)
  • Age between 18 and 65 years
  • Access to an internet-connected device (smartphone or computer)
  • Ability to participate in a tele-rehabilitation program

Who cannot take part

  • Uncontrolled severe medical conditions that could interfere with the intervention (e.g., cardiac or pulmonary diseases)
  • Participation in another clinical trial in the last 3 months
  • Pregnancy or breastfeeding
  • Physical or cognitive impairments that prevent following the exercise program

This trial has no sites in United States.

It has sites in 2 countries. Choose a country to see its sites.

About the trial

What the trial wants to find out

This randomized controlled trial will evaluate the effectiveness of a 12-week, home-based telerehabilitation program for adults with fibromyalgia (FM) combining AI-guided exercise with Pain Neuroscience Education (PNE). Fifty participants will be randomized (1:1) to the digital intervention or enhanced usual care. The primary outcome is change in pain intensity from baseline to post-intervention (week 13 ± 7 days), with secondary outcomes including physical function and health-related quality of life. Outcome assessors, the principal investigator, and the study statistician will be blinded to group allocation until database lock.

The 2 groups in the trial

  • AI-Guided Tele-rehabilitationTreatment being tested

    Participants in this arm receive a 12-week home-based tele-rehabilitation program combining AI- and computer vision-guided therapeutic exercise with Pain Neuroscience Education. Participants complete three personalized exercise sessions per week. The platform analyzes movement performance in real time, provides audiovisual corrective feedback, and adapts exercise difficulty according to individual performance and adherence data. Participants also complete one asynchronous online PNE module per week for 12 weeks. Supervising physiotherapists review adherence and safety alerts but are not involved in outcome assessment; complete blinding of treating physiotherapists is not feasible.

    Treatment: AI-Guided Exercise and Pain Neuroscience Education

  • Enhanced Usual Care for FibromyalgiaExisting treatment, for comparison

    Participants in this arm receive enhanced usual care for fibromyalgia according to clinical guidelines, including continuation of prescribed pharmacological management and general lifestyle, physical activity, and self-management advice. In addition, participants use the same digital platform with a visually identical interface and receive standard, non-specific educational materials on fibromyalgia self-management and general physical activity guidance, without AI-guided exercise feedback or structured Pain Neuroscience Education modules.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Effectiveness of Tele-Rehabilitation for Fibromyalgia Using AI-Guided Exercise and Computer Vision Combined With Pain Neuroscience Education (FIBRO IA): A Randomized Controlled Trial
Publications
Record updated
19 August 2026